Context Androstenedione, a steroid hormone and the major precursor to testo
sterone, is available without prescription and is purported to increase str
ength and athletic performance. The hormonal effects of androstenedione, ho
wever, are unknown.
Objective To determine if oral administration of androstenedione increases
serum testosterone levels in healthy men.
Design Open-label randomized controlled trial conducted between October 199
8 and April 1999.
Setting General clinical research center of a tertiary-care, university-aff
iliate hospital.
Participants Forty-two healthy men aged 20 to 40 years,
Intervention Subjects were randomized to receive oral androstenedione (eith
er 100 mg/d [n = 15] or 300 mg/d [n = 14]) or no androstenedione (n = 13) f
or 7 days.
Main Outcome Measures Changes in serum testosterone, androstenedione, estro
ne, and estradiol levels, measured by frequent blood sampling, compared amo
ng the 3 treatment groups.
Results Mean (SE) changes in the area under the curve (AUC) for serum testo
sterone concentrations were -2% (7%), -4% (4%), and 34% (14%) in the groups
receiving 0, 100, and 300 mg/d of androstenedione, respectively. When comp
ared with the control group, the change in testosterone AUC was significant
for the 300-mg/d group (P<.001) but not for the 100-mg/d group (P = .48).
Baseline testosterone levels, drawn 24 hours after androstenedione administ
ration, did not change. Mean (SE) changes in the AUC for serum estradiol co
ncentrations were 4% (6%), 42% (12%), and 128% (24%) in the groups receivin
g 0, 100, and 300 mg/d of androstenedione, respectively. When compared with
the control group, the change in the estradiol AUC was significant for bot
h the 300-mg/d (P<.001) and 100-mg/d (P = .002) groups. There was marked va
riability in individual responses for all measured sex steroids.
Conclusions Our data suggest that oral androstenedione, when given in dosag
es of 300 mg/d, increases serum testosterone and estradiol concentrations i
n some healthy men.